Albendazole-Induced Anagen Effluvium

    December 2019 in “ JAAD Case Reports
    Mondana Ghias, Bijal Amin, Allison Kutner
    Image of study
    TLDR A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.
    The document reports a case of a 74-year-old woman who experienced rapid-onset, acute hair loss on her scalp and body, including eyebrows, chin, extremities, and genitalia, two weeks after completing a 5-day course of albendazole (400 mg every 12 hours) for Toxocara antibodies. She had no prior history of hair loss. Examination and histopathology supported a diagnosis of anagen effluvium, a nonscarring alopecia that occurs after a toxic or inflammatory insult and is generally reversible upon discontinuation of the offending agent. The patient showed mild improvement of hair regrowth one month after initial presentation, despite being lost to follow-up. The case emphasizes that although albendazole has a relatively benign side-effect profile, it can rarely cause anagen effluvium, which is generally reversible with the cessation of the drug.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    0 / 0 results
    — no results

    Similar Research

    5 / 55 results
      Drug-Associated Alopecia

      research Drug-Associated Alopecia

      63 citations, March 1995 in “International Journal of Dermatology”
      Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.
      Index

      research Index

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      The document is a detailed medical reference on skin and genetic disorders.
      Diseases of Hair and Nails

      research Diseases of Hair and Nails

      3 citations, January 2012 in “Elsevier eBooks”
      The document says that there are treatments for hair and nail diseases.